(Q43048085)

12 November 2017

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia (English)

1 reference

12 November 2017

1 reference

5

1 reference

12 November 2017

Camps J

1

1 reference

12 November 2017

Castilla A

series ordinal

2

1 reference

12 November 2017

Ruiz J

series ordinal

3

1 reference

12 November 2017

Civeira MP

series ordinal

4

1 reference

12 November 2017

1 March 1993

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

17

1 reference

12 November 2017

390-396

1 reference

12 November 2017

3

1 reference

Treatment of chronic non-A, non-B hepatitis wih acyclovir: pilot study

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Enhanced detection by PCR of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Colchicine in the treatment of cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980223-5

7 January 2021

10.1016/S0168-8278(05)80223-5

Identifiers

DOI

1 reference

12 November 2017

1 reference